DexCom, Inc. (DXCM)
91.04
-1.30
(-1.41%)
USD |
NASDAQ |
Aug 24, 16:00
91.52
+0.48
(+0.53%)
After-Hours: 20:00
DexCom Enterprise Value : 34.30B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 34.30B |
| August 20, 2026 | 33.50B |
| August 19, 2026 | 33.37B |
| August 18, 2026 | 33.27B |
| August 17, 2026 | 32.95B |
| August 14, 2026 | 33.32B |
| August 13, 2026 | 33.98B |
| August 12, 2026 | 33.72B |
| August 11, 2026 | 33.24B |
| August 10, 2026 | 32.53B |
| August 07, 2026 | 31.44B |
| August 06, 2026 | 30.78B |
| August 05, 2026 | 30.65B |
| August 04, 2026 | 32.26B |
| August 03, 2026 | 32.40B |
| July 31, 2026 | 30.95B |
| July 30, 2026 | 27.58B |
| July 29, 2026 | 27.81B |
| July 28, 2026 | 27.70B |
| July 27, 2026 | 27.14B |
| July 24, 2026 | 26.45B |
| July 23, 2026 | 26.05B |
| July 22, 2026 | 26.41B |
| July 21, 2026 | 27.66B |
| July 20, 2026 | 28.02B |
| Date | Value |
|---|---|
| July 17, 2026 | 28.38B |
| July 16, 2026 | 28.88B |
| July 15, 2026 | 26.90B |
| July 14, 2026 | 27.42B |
| July 13, 2026 | 28.27B |
| July 10, 2026 | 27.74B |
| July 09, 2026 | 27.01B |
| July 08, 2026 | 27.40B |
| July 07, 2026 | 27.22B |
| July 06, 2026 | 26.77B |
| July 02, 2026 | 26.34B |
| July 01, 2026 | 25.44B |
| June 30, 2026 | 24.87B |
| June 29, 2026 | 25.97B |
| June 26, 2026 | 26.04B |
| June 25, 2026 | 25.46B |
| June 24, 2026 | 25.89B |
| June 23, 2026 | 25.57B |
| June 22, 2026 | 25.62B |
| June 18, 2026 | 26.94B |
| June 17, 2026 | 26.46B |
| June 16, 2026 | 27.20B |
| June 15, 2026 | 27.61B |
| June 12, 2026 | 28.05B |
| June 11, 2026 | 28.01B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 229.49B |
| Insulet Corp. | 10.69B |
| Baxter International, Inc. | 20.30B |
| Globus Medical, Inc. | 11.18B |
| Stryker Corp. | 138.34B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 249.10M |
| Revenue (Quarterly) | 1.308B |
| Total Expenses (Quarterly) | 1.059B |
| EPS Diluted (Quarterly) | 0.6429 |
| Gross Profit Margin (Quarterly) | 63.44% |
| Profit Margin (Quarterly) | 19.04% |
| Earnings Yield | 2.78% |
| Operating Earnings Yield | 3.15% |
| Normalized Earnings Yield | 2.783 |